Personalized predictions of patient outcomes during and after hospitalization using artificial intelligence.
Health care economics
Outcomes research
Risk factors
Journal
NPJ digital medicine
ISSN: 2398-6352
Titre abrégé: NPJ Digit Med
Pays: England
ID NLM: 101731738
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
09
2019
accepted:
28
02
2020
entrez:
15
4
2020
pubmed:
15
4
2020
medline:
15
4
2020
Statut:
epublish
Résumé
Hospital systems, payers, and regulators have focused on reducing length of stay (LOS) and early readmission, with uncertain benefit. Interpretable machine learning (ML) may assist in transparently identifying the risk of important outcomes. We conducted a retrospective cohort study of hospitalizations at a tertiary academic medical center and its branches from January 2011 to May 2018. A consecutive sample of all hospitalizations in the study period were included. Algorithms were trained on medical, sociodemographic, and institutional variables to predict readmission, length of stay (LOS), and death within 48-72 h. Prediction performance was measured by area under the receiver operator characteristic curve (AUC), Brier score loss (BSL), which measures how well predicted probability matches observed probability, and other metrics. Interpretations were generated using multiple feature extraction algorithms. The study cohort included 1,485,880 hospitalizations for 708,089 unique patients (median age of 59 years, first and third quartiles (QI) [39, 73]; 55.6% female; 71% white). There were 211,022 30-day readmissions for an overall readmission rate of 14% (for patients ≥65 years: 16%). Median LOS, including observation and labor and delivery patients, was 2.94 days (QI [1.67, 5.34]), or, if these patients are excluded, 3.71 days (QI [2.15, 6.51]). Predictive performance was as follows: 30-day readmission (AUC 0.76/BSL 0.11); LOS > 5 days (AUC 0.84/BSL 0.15); death within 48-72 h (AUC 0.91/BSL 0.001). Explanatory diagrams showed factors that impacted each prediction.
Identifiants
pubmed: 32285012
doi: 10.1038/s41746-020-0249-z
pii: 249
pmc: PMC7125114
doi:
Types de publication
Journal Article
Langues
eng
Pagination
51Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no competing interests.
Références
JAMA. 2016 Dec 13;316(22):2402-2410
pubmed: 27898976
J Oncol Pract. 2015 Mar;11(2):e177-81
pubmed: 25585616
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
J Eval Clin Pract. 2017 Jun;23(3):524-529
pubmed: 27696638
Comput Methods Programs Biomed. 2018 Oct;164:49-64
pubmed: 30195431
JAMA Intern Med. 2016 Apr;176(4):484-93
pubmed: 26954564
Science. 2018 Dec 7;362(6419):1140-1144
pubmed: 30523106
BMJ Qual Saf. 2017 Oct;26(10):799-805
pubmed: 28416652
Nat Med. 2018 Oct;24(10):1559-1567
pubmed: 30224757
JAMA. 2015 Jul 7;314(1):25-6
pubmed: 26151261
BMJ. 2018 Apr 30;361:k1479
pubmed: 29712648
JAMA Intern Med. 2013 Apr 22;173(8):632-8
pubmed: 23529115
Front Neurorobot. 2013 Dec 04;7:21
pubmed: 24409142
JAMA. 2017 Aug 8;318(6):517-518
pubmed: 28727867
JAMA. 2018 Dec 25;320(24):2542-2552
pubmed: 30575880
Ann Intern Med. 2018 May 15;168(10):733-734
pubmed: 29582072
Med Care. 2017 Mar;55(3):285-290
pubmed: 27755392
JAMA Intern Med. 2014 Jul;174(7):1095-107
pubmed: 24820131
NPJ Digit Med. 2018 May 8;1:18
pubmed: 31304302
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215